Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/27/2021
NH Reports on Chinese OTC Eye Care Market in MAT 09/2020
1/27/2021
NH Reports Latest Data on Chinese Smoking Control Market
1/27/2021
NH Reports on Chinese OTC Sleep Aids Market in MAT 09/2020
1/27/2021
Novartis Aims to Double China Business by 2024
1/27/2021
Biogen Employee Traveling to China with COVID-19 Last March Handed A S...
1/27/2021
CDE Solicits Comments on Two Technical Documents for Pharmaceutical St...
1/26/2021
EUSA and BeiGene Announce Acceptance of a Biologics License Applicati...
1/26/2021
Antengene Granted Chinese IND Approval for ATG-010 (Selinexor) in Co...
1/26/2021
AstraZeneca Granted Additional Indiciation for Asthma Drug Symbicort T...
1/26/2021
Photocure Partners with Asieris MediTech to Commercialize Hexvix in Ma...
1/26/2021
CDE Issues the Technical Guidelines for Bioequivalence Study of 11 Dru...
1/26/2021
CDE Issues the Technical Guidelines for Drug Interaction Research
1/25/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (36th ...
1/25/2021
CDE Issues the ICH Guidelines E9(R1), S5(R3) and S11
1/25/2021
NMPA Revises Packages Inserts of Gefitinib Tablets
1/25/2021
NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
1/25/2021
China's Meituan to Shut Down Healthcare Mutual Aid Program
1/22/2021
Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...
1/22/2021
AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...
1/22/2021
Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China
1/22/2021
GSK Granted Priority Review for NDA of Two-in-One HIV Drug Juluca in C...
1/22/2021
Recent Executive Moves
1/21/2021
Jemincare Initiates Phase I Trial of Anti-SARS-Cov-2 Neutralizing Anti...
1/21/2021
Chinese Couple Plead Guilty To Stealing Trade Secrets From Ohio Child...
1/21/2021
ADB and Jointown Partner To Expand Pharmaceutical Distribution Facilit...
1/21/2021
Sinovac Increases Vaccine Production to Ensure Global Supply
1/21/2021
Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
1/21/2021
Coronavirus in China: 2021 Outlook Brightens for Health Care Operators...
1/21/2021
New Judicial Interpretation in China Strengthens Protection of Trade S...
1/21/2021
Chinese Civil Code Introduces Punitive Damages Against IP Infringement
Page:
217
/
789
Total number of articles:
23668
:
[First]
[<<]
[215]
[216]
[217]
[218]
[219]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit